🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to evaluate immune non-inferiority, safety and lot-to-lot con...
Status
Completed
Location
Nepalgunj medical college
Start Date
2021-10-06
Trial ID
NCT04760236
Treatments Being Tested
Data demonstrates that Shanchol™ (killed bivalent oral cholera vaccine) pro...
Status
Completed
Location
National Institute of Cholera and Enteric Diseases
Start Date
2012-12
Trial ID
NCT01579448
To compare the ability of a single dose of PXVX0200 at two different dose l...
Status
Completed
Location
Centre pour le Développement des Vaccins, Mali (CVD-Mali)
Start Date
2014-07
Trial ID
NCT02145377
Treatments Being Tested
Bangladesh remains endemic for cholera, which experiences biannual outbreak...
Status
Completed
Location
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)
Start Date
2012-12-09
Trial ID
NCT02027207
A Phase III randomized, modified double-blind, multi-centric, comparative s...
Status
Unknown
Location
King George Hospital,Visakhapatnam
Start Date
2022-02-22
Trial ID
NCT05507229
Treatments Being Tested
The aim of the study is to generate safety and immunogenicity data with Sha...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02434822
The aim of the study is to generate safety and immunogenicity data with Ora...
Status
Completed
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT01949675
To evaluate and compare the safety and immunogenicity of the Cholvax with S...
Status
Completed
Location
International Centre for Diarrhoeal Disease Research, Bangladesh
Start Date
2016-04
Trial ID
NCT02742558
The purpose of this study is to determine whether the killed bivalent (O1 a...
Status
Completed
Location
Christian Medical College
Start Date
2012-03
Trial ID
NCT00760825
Treatments Being Tested
A Phase III randomized, modified double-blind, multi-centric, comparative s...
Status
Unknown
Location
King George Hospital, Visakhapatnam
Start Date
2023-02-04
Trial ID
NCT05732766
Treatments Being Tested